Furthermore, overexpression of NEK2 suppressed the expression of the BH3-only genes BAD and PUMA and upregulated the expression of pro-survival genes BCL-xL and MCL-1, indicating a possible role of NEK2 in cancer drug resistance via mitotic slippage. Here, NEK2 is linked to cancer.